Download PDF
CC BY-NC-ND 4.0 · SynOpen 2021; 05(04): 314-320
DOI: 10.1055/a-1681-4544
paper

Mild Biamidine-Transfer Conditions for the Synthesis of Aliphatic Biguanides

Rostyslav Bardovskyi‡
a   Université Côte d’Azur, ICN, UMR 7272 CNRS, 06108 Nice, France
,
Marie Fabre‡
a   Université Côte d’Azur, ICN, UMR 7272 CNRS, 06108 Nice, France
,
Cyril Ronco  ∗
a   Université Côte d’Azur, ICN, UMR 7272 CNRS, 06108 Nice, France
,
Rachid Benhida  ∗
a   Université Côte d’Azur, ICN, UMR 7272 CNRS, 06108 Nice, France
b   Mohamed VI Polytechnic University, UM6P, 43150 BenGuerir, Morocco
› Author AffiliationsThe authors are grateful for the financial support from the Research Fund of the Cancéropôle Provence-Alpes-Côte d'Azur (PACA) and the SATT-Sud Est (EmA grant – Emergence et Accompagnement). The Centre National de la Recherche Scientifique (CNRS), Université Côte d’Azur, ANR, and Région Sud are also acknowledged for additional funding.
› Further Information
   Permissions and Reprints All articles of this category


Abstract

This study focuses on the development of new synthetic pathways to monosubstituted biguanides from amines. An exhaustive comparison of the conditions and reagents used for biamidine transfer was performed. New reagents were synthesized and optimized conditions for the synthesis of substituted biguanides under mild conditions were developed. Eventually, two high-yielding and straightforward protocols for the transfer of a biamidine group to various amines are proposed and their scope and limitations have been explored. These conditions include: i) a direct chromatography-free procedure and ii) an eco-friendly procedure in water compatible with bioinspired molecules. They are particularly efficient for the demanding conversion of aliphatic amines.

Key words

biguanide - biamidine transfer - mild conditions - biocompatible protocol - guanidine derivatives

Supporting Information

    Supporting information for this article is available online at https://doi.org/10.1055/a-1681-4544.
  • Supporting Information


Publication History

Received: 27 July 2021

Accepted: 06 August 2021

Accepted Manuscript online:
28 October 2021

Article published online:
18 November 2021

© 2021. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Kathuria D, Bankar AA, Bharatam PV. J. Mol. Struct. 2018; 1152: 61
    Crossref
  • 2 Elmar B, Stach K, Schmidt FH, Heerdt R, Weber H. US4017539A, 1977
    PubMed
  • 3 Mayer S, Daigle DM, Brown ED, Khatri J, Organ MG. J. Comb. Chem. 2004; 6: 776
    CrossrefPubMed
  • 4 Smolka A, Friedreich A. Monatsh. Chem. 1888; 9: 227
    Crossref
  • 5 Tonelli M, Espinoza S, Gainetdinov RR, Cichero E. Eur. J. Med. Chem. 2017; 127: 781
    CrossrefPubMed
  • 6 van Kuijk SJ. A, Parvathaneni NK, Niemans R, van Gisbergen MW, Carta F, Vullo D, Pastorekova S, Yaromina A, Supuran CT, Dubois LJ, Winum J.-Y, Lambin P. Eur. J. Med. Chem. 2017; 127: 691
    CrossrefPubMed
  • 7 Suyama T, Soga T, Miyauchi KA. Nippon Kagaku Kaishi 1989; 5: 884
    Crossref
  • 8 Obianom ON, Coutinho AL, Yang W, Yang H, Xue F, Shu Y. Mol. Pharm. 2017; 14: 2726
    CrossrefPubMed
  • 9 Kim SW, Kim HW, Yoo SH, Lee JS, Heo HJ, Lee HB, Kook JA, Lee YW, Kim MJ, Cho W. WO2015160220A1, 2015
    PubMed
  • 10 Fortun S, Schmitzer AR. ACS Omega 2018; 3: 1889
    CrossrefPubMed
  • 11 Fortun S, Schmitzer AR. Can. J. Chem. 2020; 98: 251
    Crossref
  • 12 Guo Z, Cainmldge AN, Mckiilop A. Tetrahedron Lett. 1999; 40: 6999
    Crossref
  • 13 Chen HY, Zhao M, Tan J.-H, Huang Z.-S, Liu G.-F, Ji L.-N, Mao Z.-W. Tetrahedron 2014; 70: 2378
    Crossref
  • 14 Yan Q, Zhao Y. Chem. Sci. 2015; 6: 4343
    CrossrefPubMed
  • 15 Hao X, Sang W, Hu J, Yan Q. ACS Macro Lett. 2017; 6: 1151
    CrossrefPubMed
  • 16 Shuhui C, Zhifei F, Jian L, Miaorong L, Yang Z. AU2017306487A1, 2018
    PubMed
  • 17 Vaillancourt VA, Larsen SD, Tanis SP, Burr JE, Connell MA, Cudahy MM, Evans BR, Fisher PV, May PD, Meglasson MD, Robinson DD, Stevens FC, Tucker JA, Vidmar TJ, Yu JH. J. Med. Chem. 2001; 44: 1231
    CrossrefPubMed
  • 18 Igashira-Kamiyama A, Kajiwara T, Nakano M, Konno T, Ito T. Inorg. Chem. 2009; 48: 11388
    CrossrefPubMed
  • 19 Eilingsfeld H, Scheuermann H. Chem. Ber. 1967; 100: 1874
    Crossref
  • 20 Bando S, Ichikawa E, Odo K. J. Synth. Org. Chem., Jpn. 1970; 28: 521
    Crossref
  • 21 Kawano K. Bull. Kyushu Inst. Technol., Math., Nat. Sci. 1962; 12: 69
  • 22 Kim HW, Jeong JK, Lee JS, Heo HJ, Lee HB, Kook JA, Kim SW. WO2016080810 A2, 2016
    PubMed
  • 23 Shapiro SL, Parrino VA, Freedman L. J. Am. Chem. Soc. 1959; 81: 3728
    Crossref
  • 24 Kim SW, Kim HW, Yoo SH, Lee JS, Heo HJ, Lee HB, Kook JA, Lee YW, Kim MJ, Cho W. US2017073331 A1, 2015
    PubMed
  • 25 Ma X, Tan S.-T, Khoo C.-L, Sim H.-M, Chan L.-W, Chui W.-K. Bioorg. Med. Chem. Lett. 2011; 21: 5428
    CrossrefPubMed
  • 26 Makowska A, Saczewski F, Bednarski PJ, Saczewski J, Balewski Ł. Molecules 2018; 23: 1
    CrossrefPubMed
  • 27 Husain MI, Srivastava VP. Indian J. Chem., Sect. B. Org. Chem. Incl. Med. Chem. 1984; 23B: 789
  • 28 Corbellini A, Lugaro G, Giannattasio G, Torti G. Arch. Ital. Patol. Clin. Tumori 1967; 10: 197
    PubMed
  • 29 Shapiro SL, Freedman L. US2961377A, 1957
    PubMed
  • 30 Kim HW, Jeong JK, Lee JS, Hye JH, Kook JA, Kim SW. US2020/0277255 A1, 2020
    PubMed